Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,752.50
+15.50 (0.89%)
Mar 2, 2026, 3:30 PM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.17 trillion as of March 2, 2026. Its market cap has decreased by -0.73% in one year.
Market Cap
4.17T
Enterprise Value
3.94T
Revenue
568.09B
Ranking
n/a
PE Ratio
38.22
Stock Price
1,752.50
Market Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.17T, an increase of 14,994.32%. That is a compound annual growth rate of 22.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.17T | 1.01% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.70T |
| Cipla | 1.09T |
| Mankind Pharma | 927.82B |
| Zydus Lifesciences | 927.45B |
| Aurobindo Pharma | 708.81B |
| Alkem Laboratories | 674.29B |
| Glenmark Pharmaceuticals | 602.98B |
| Laurus Labs | 580.78B |